InMed Pharmaceuticals Inc (INM) Stock Price, Quote, News & History

INMNASDAQ
$0.7714
0.00931.22%
At close: Apr 24, 5:00 PM EST
$0.7980
0.02663.45%
After Hours: Apr 24, 8:38 AM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-7.42M
Investing Cash Flow (TTM)
0
Financing Cash Flow (TTM)
10.96M
Free Cash Flow (TTM)
-7.42M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
3.54M

Valuation Metrics

Enterprise Value
-$3.87M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
0.44
PB Ratio (TTM)
0.26
Earnings Yield % (TTM)
-377.90%
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$2.89

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$6.95M
Debt to Equity
0.06
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$0.78
Close
$0.77
Volume / Avg.
41.04K / 105.83K
Day Range
$0.75 - $0.78
52 Wk Range
0.57 - 7.98
Market Cap
$2.64M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
55
Short Interest
2.9%
Days to Cover
2.68

About

Sector
Health Care
Industry
Pharmaceuticals
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment i...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy InMed Pharmaceuticals (INM) stock?

A

You can purchase shares of InMed Pharmaceuticals (NASDAQ:INM) through any online brokerage.

View our list of the best stock brokerages

Q

Who are InMed Pharmaceuticals (INM) competitors?

A

There are no as such competitors for InMed Pharmaceuticals.

Q

What is the forecast, or price target, for InMed Pharmaceuticals (INM) stock?

A

There is no analysis for InMed Pharmaceuticals to provide a consensus price target.

Q

What is the current price for InMed Pharmaceuticals (INM)?

A

The stock price for InMed Pharmaceuticals (NASDAQ: INM) is $0.798 last updated April 24, 2026 at 8:38 AM EDT.

Q

Does InMed Pharmaceuticals (INM) pay a dividend?

A

There are no upcoming dividends for InMed Pharmaceuticals.

Q

When is InMed Pharmaceuticals (NASDAQ:INM) reporting earnings?

A

InMed Pharmaceuticals does not have any upcoming earnings scheduled.

Q

Is InMed Pharmaceuticals (INM) going to split?

A

There is no upcoming split for InMed Pharmaceuticals.

Q

What sector and industry does InMed Pharmaceuticals (INM) operate in?

A

InMed Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.